Meeting
2023 ASCO Annual Meeting
Patient- versus clinician-reported symptoms in the POLARIX study.
Authors
Carrie A. Thompson
Mayo Clinic College of Medicine, Rochester, MN
Carrie A. Thompson , Neha Mehta-Shah , Christopher Flowers , Gilles A. Salles , Herve Tilly , Neil Sun Chua , René-Olivier Casasnovas , Fiona Miall , Tae Min Kim , Cheng-Hong Tsai , Sunita Dwivedy Nasta , Seung Tae Lee , Veronica Craine , Avrita Campinha-Bacote , Jamie H. Hirata , Calvin Lee , Matthew Dean Sei Sugidono , Jonathan W. Friedberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Clinical Trial Registration Number
NCT03274492
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 12100)
DOI
10.1200/JCO.2023.41.16_suppl.12100
Abstract #
12100
Poster Bd #
468
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Preliminary phase II results of selinexor, an oral selective inhibitor of nuclear export in patients with heavily pretreated gynecological cancers.
First Author: Ignace Vergote
Poster
2024 ASCO Annual Meeting
A phase II trial of AZD1775 plus carboplatin-paclitaxel in squamous cell lung cancer (SqCLC).
First Author: Bruna Pellini
Poster
2024 ASCO Annual Meeting
Neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery followed by adjuvant docetaxel and S-1 for patients with large type 3 or type 4 gastric cancer: Short-term outcomes of the phase II OGSG1902 trial.
First Author: Hiromichi Miyagaki
Poster
2023 ASCO Annual Meeting
Association between patient-reported outcomes and therapeutic outcomes in patients with breast cancer: A pooled individual-participant data analysis.
First Author: Natansh Modi